简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2016-01-20 16:31 AtriCure Announces Approval for the AtriClip in Japan
2016-01-18 10:05 Samsung Bioepis Enters the European Biopharmaceutical Market with Benepali®, the First Fusion Protein Biosimilar Approved by the European Commission
2016-01-14 10:27 Russell Reynolds Associates Hires Waseem Noor to Strengthen Its Global Healthcare and Nonprofit Practices
2016-01-13 17:32 Boehringer Ingelheim and Arena Pharmaceuticals Collaborate to Advance Research in Schizophrenia
2016-01-13 16:17 First Implant Completed in Thoracoabdominal Aortic Aneurysm Clinical Study
2016-01-12 14:19 Takeda and enGene Establish Strategic Alliance to Develop Novel Therapeutics for Gastrointestinal Diseases
2016-01-08 14:27 Takeda to Present at the 34th Annual J.P. Morgan Healthcare Conference
2016-01-06 14:44 22nd Century Files Modified Risk Tobacco Product Application with the FDA for World’s Lowest Nicotine Tobacco Cigarettes
2016-01-06 14:01 Takeda Acquires U.S. Biologics Manufacturing Facility
2016-01-06 11:15 CORRECTING and REPLACING Now Published in the Annals of Surgery: Long-Term Favorable Results Demonstrate GORE BIO-A Tissue Reinforcement Efficacy in Complex Ventral Hernia Repairs
2016-01-06 10:59 Misfit Introduces Ray, The Most Versatile Activity Tracker Yet
2016-01-05 16:20 Bioventus Launches DUROLANE® for Osteoarthritis Patients in Taiwan
2016-01-05 10:27 Merck, Pfizer and Syndax Announce Collaboration to Evaluate Combination of Avelumab and Entinostat in Ovarian Cancer
2016-01-05 10:19 Cellular Regenerative Therapy Greeted by French Minister of Health
2016-01-04 11:28 Herbalife Appoints Filipino Doctor to Its Nutrition Advisory Board
2015-12-28 13:38 CORRECTING and REPLACING Takeda Provides Further Information about Its New Business Venture with Teva
2015-12-23 13:17 Boehringer Ingelheim Invests in Europe: Pharma Company Expands Biopharmaceutical Production at Vienna Site
2015-12-23 13:09 Merck and Pfizer Advance Clinical Development Program with Two Additional Phase III Trials of Avelumab
2015-12-21 16:42 Boehringer Ingelheim 3rd-generation EGFR TKI, BI 1482694, receives FDA Breakthrough Therapy Designation in lung cancer
2015-12-21 14:21 Oral REVLIMID® Plus Dexamethasone Granted Approval for Treatment of Patients with Newly Diagnosed Multiple Myeloma in Japan

Business Wire Weibo

Press Releases

Latest Releases